These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 8704629)
21. Prolonged bleeding time induced by anticoagulant glycosaminoglycans in dogs is associated with the inhibition of thrombin-induced platelet aggregation. Kitazato K; Kitazato KT; Sasaki E; Minamiguchi K; Nagase H Thromb Res; 2003; 112(1-2):83-91. PubMed ID: 15013278 [TBL] [Abstract][Full Text] [Related]
23. Relative antithrombotic and antihemostatic effects of protein C activator versus low-molecular-weight heparin in primates. Gruber A; Marzec UM; Bush L; Di Cera E; Fernández JA; Berny MA; Tucker EI; McCarty OJ; Griffin JH; Hanson SR Blood; 2007 May; 109(9):3733-40. PubMed ID: 17227834 [TBL] [Abstract][Full Text] [Related]
24. Long duration of anticoagulant activity and protective effects of acharan sulfate in vivo. Li DW; Lee IS; Sim JS; Toida T; Linhardt RJ; Kim YS Thromb Res; 2004; 113(1):67-73. PubMed ID: 15081567 [TBL] [Abstract][Full Text] [Related]
25. Antithrombotic activity of dermatan sulphates, heparins and their combination in an animal model of arterial thrombosis. Iacoviello L; D'Adamo MC; Pawlak K; Polishchuck R; Wollny T; Buczko W; Donati MB Thromb Haemost; 1996 Dec; 76(6):1102-7. PubMed ID: 8972038 [TBL] [Abstract][Full Text] [Related]
26. The characteristics, biodistribution and bioavailability of a chitosan-based nanoparticulate system for the oral delivery of heparin. Chen MC; Wong HS; Lin KJ; Chen HL; Wey SP; Sonaje K; Lin YH; Chu CY; Sung HW Biomaterials; 2009 Dec; 30(34):6629-37. PubMed ID: 19767097 [TBL] [Abstract][Full Text] [Related]
27. Effect of new synthetic heparin mimetics on whole blood thrombin generation in vivo and in vitro in rats. Hérault JP; Bernat A; Gaich C; Herbert M Thromb Haemost; 2002 Feb; 87(2):238-44. PubMed ID: 11858483 [TBL] [Abstract][Full Text] [Related]
28. Anticoagulative effects of the inhaled low molecular weight heparin certoparin in healthy subjects. Scheuch G; Brand P; Meyer T; Herpich C; Müllinger B; Brom J; Weidinger G; Kohlhäufl M; Häussinger K; Spannagl M; Schramm W; Siekmeier R J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 2):603-14. PubMed ID: 18204174 [TBL] [Abstract][Full Text] [Related]
29. [Effect of chitosan sulfates on lipoprotein lipase activity]. Solov'eva MA; Gorbacheva IN; Vikhoreva GA; Gal'braĭkh LS; Ryzhenkov VE Vopr Med Khim; 1994; 40(2):37-9. PubMed ID: 8160428 [TBL] [Abstract][Full Text] [Related]
30. Influence of molecular weight of chemically sulfated citrus pectin fractions on their antithrombotic and bleeding effects. Cipriani TR; Gracher AH; de Souza LM; Fonseca RJ; Belmiro CL; Gorin PA; Sassaki GL; Iacomini M Thromb Haemost; 2009 May; 101(5):860-6. PubMed ID: 19404539 [TBL] [Abstract][Full Text] [Related]
32. Absorption and antithrombotic activity of unfractioned heparin after intraduodenal administration in rats. Costantini V; Deveglia R; Stabile A; Nenci GG Blood Coagul Fibrinolysis; 2000 Jan; 11(1):7-13. PubMed ID: 10691095 [TBL] [Abstract][Full Text] [Related]
33. [Comparative evaluation of the anticoagulant activity of the sodium and calcium salts of heparin, isolated from swine intestinal mucosa]. Ushkalova EA; Kremneva VF; Ovchinnikova LK; Shcheglova NV Farmakol Toksikol; 1989; 52(3):51-5. PubMed ID: 2792354 [TBL] [Abstract][Full Text] [Related]
34. Anticoagulant activity of a sulfated chitosan. Vongchan P; Sajomsang W; Subyen D; Kongtawelert P Carbohydr Res; 2002 Jul; 337(13):1239-42. PubMed ID: 12110200 [TBL] [Abstract][Full Text] [Related]
35. [Effect of xanthine derivatives on thrombocyte aggregation and other hemostatic indices]. Lakin KM; Ovnatanova MS; Matiashova MA; Mashkovskiĭ MD Biull Eksp Biol Med; 1980 Feb; 89(2):181-2. PubMed ID: 7370418 [TBL] [Abstract][Full Text] [Related]
36. Controlled release of fibroblast growth factors and heparin from photocrosslinked chitosan hydrogels and subsequent effect on in vivo vascularization. Ishihara M; Obara K; Ishizuka T; Fujita M; Sato M; Masuoka K; Saito Y; Yura H; Matsui T; Hattori H; Kikuchi M; Kurita A J Biomed Mater Res A; 2003 Mar; 64(3):551-9. PubMed ID: 12579570 [TBL] [Abstract][Full Text] [Related]
37. Chemotherapy-induced activation of hemostasis: effect of a low molecular weight heparin (dalteparin sodium) on plasma markers of hemostatic activation. Weitz IC; Israel VK; Waisman JR; Presant CA; Rochanda L; Liebman HA Thromb Haemost; 2002 Aug; 88(2):213-20. PubMed ID: 12195692 [TBL] [Abstract][Full Text] [Related]
38. Hemostatic activation under anticoagulant treatment: a comparison of unfractionated heparin vs. nadroparin in the treatment of proximal deep vein thrombosis. Stricker H; Marchetti O; Haeberli A; Mombelli G Thromb Haemost; 1999 Oct; 82(4):1227-31. PubMed ID: 10544903 [TBL] [Abstract][Full Text] [Related]
39. [Effect of delagil on the blood coagulation system and the interrelation with heparin]. Ovchinnikova LK; Pomortseva IV Farmakol Toksikol; 1985; 48(2):77-81. PubMed ID: 3996575 [TBL] [Abstract][Full Text] [Related]
40. Arterial antithrombotic effects of aspirin, heparin, enoxaparin and clopidogrel alone, or in combination, in the rat. Daykin HJ; Sturgeon SA; Jones C; Wright CE Thromb Res; 2006; 118(6):755-62. PubMed ID: 16410020 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]